In addition, the silencing of SHMT2 in OSCC cells can affect cell cycle regulatory factors and induce cell G1 phase arrest, resulting in decreased cancer cell growth as well as inhibited cancer proliferation in vivo [44]. This evidence concerns the gene SHMT2 and cancer.